Risk modelling the mortality impact of antimicrobial resistance in secondary pneumococcal pneumonia infections during the 2009 influenza pandemic
Antimicrobial resistance (AMR) is an important factor for consideration in pandemic preparedness. Any reduction in treatability poses a potential risk to national and international security and economic stability when applied to pandemic-related pathogens (McArthur and Tsang, 2017). Increasing AMR among pathogens responsible for the development of community-acquired pneumonia (CAP) (e.g., Streptococcus pneumoniae and Haemophilus influenzae) (Adam, 2002) is especially concerning given their propensity to cause bacterial infections secondary to viral influenza.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Carrie E. Barnes, C. Raina MacIntyre Source Type: research
More News: Antimicrobial Resistance | Flu Pandemic | Haemophilus Influenzae (Hib) | Infectious Diseases | Influenza | Pandemics | Pneumonia